Arvinas, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARVN Nasdaq 2830 www.arvinas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arvinas, Inc.

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease - Oct 7th, 2026 5:00 am
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders® - Oct 1st, 2026 2:01 pm
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sep 29th, 2026 2:01 pm
Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate - Sep 28th, 2026 5:00 am
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains? - Sep 18th, 2026 10:31 am
AdvanCell Appoints Sean Cassidy as Chief Financial Officer - Sep 15th, 2026 6:00 am
Arvinas (ARVN) Just Made Protein Degrader History With FDA Nod - Sep 9th, 2026 12:22 am
Arvinas to Participate in Upcoming Investor Conferences - Sep 3rd, 2026 2:01 pm
Can KT-621 Mark a Turning Point for Kymera Therapeutics? - Sep 3rd, 2026 9:50 am
Arvinas (ARVN) Q2 2026 Earnings Call Transcript - Aug 11th, 2026 12:05 pm
Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says - Aug 10th, 2026 10:01 am
Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know - Aug 6th, 2026 10:00 am
Arvinas, Inc. Q2 2026 Earnings Call Summary - Aug 4th, 2026 3:41 pm
Arvinas Q2 Earnings Call Highlights - Aug 4th, 2026 8:04 am
Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates - Aug 4th, 2026 6:50 am
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 4th, 2026 5:00 am
Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026 - Jul 28th, 2026 5:00 am
uniQure (QURE) Soars 78.4%: Is Further Upside Left in the Stock? - Jun 18th, 2026 5:30 am